We want to help the world overcome Covid-19. Research is the best way to save lives – but more investment in accessible treatments, tests and vaccines is urgently needed to change the course of the pandemic.
We're supporting research and development, and working to make sure that any new vaccines, tests and treatments are mass-produced quickly and reach everyone who needs them.
We’re doing this by working with others:
The pandemic has inspired unprecedented global research collaboration. The same level of collaboration is needed between countries and international organisations to make sure that vaccines, treatments and tests are globally accessible.
Governments and international organisations must invest now in research and development of diagnostics, treatments and vaccines. And they must support fair access to these lifesaving tools – so they become available to the most at-risk populations everywhere, regardless of ability to pay.
To achieve this, $35 billion is needed. Investing now, at scale and as a collective global effort, is the only way to save lives, reduce the spread of Covid-19 and bring societies and economies back on track.
Governments and private and philanthropic funders can support research into and equitable access to Covid-19 tests, treatments and vaccines.
We’d love to hear from you on how we can work together to change the course of the pandemic.
Here's what you need to know if you're applying for one of our research grants, or hold a Wellcome grant.
The best of humanity has shone through the gloom of 2020. The dedication of scientists across the globe has been remarkable, not just for producing a string of lifesaving breakthroughs but for doing so at an unprecedented pace.
How do RNA vaccines work and are they safe?
Read more articles on Covid-19.
[Summary] A commitment by Wellcome, UNICEF, the WHO, and the World Economic Forum to embed three principles across our mental health work: lived experience, local innovation, and larger than healthcare.
[Summary] This report presents the results of the fifth Wellcome Monitor. It focuses on findings about Covid-19.
[Summary] A roadmap to making lifesaving monoclonal antibody treatments affordable and available, particularly to those living in low- and middle-income countries.
[Summary] Our polling of more than 6,000 adults in the UK, the USA, Germany and France shows strong public support for making sure that any new coronavirus treatments and vaccines are first made available to those who need them most.
